Summary & Overview
CPT 35665: Iliac-to-Femoral Bypass with Synthetic Graft
CPT code 35665 identifies an open vascular surgical procedure in which a synthetic graft is used to bypass an occluded iliac artery to the femoral artery. This intervention is a key component of arterial revascularization for patients with significant aortoiliac occlusive disease and limb-threatening ischemia. Nationally, such bypass procedures remain important for restoring lower-extremity perfusion when endovascular options are unsuitable or have failed.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find clinical context for when an iliac-to-femoral synthetic graft bypass is used, expected sites of service, and the service line classification. The publication outlines commonly reported modifiers and identifies gaps where specific taxonomy and diagnosis code mappings are not provided in the input (Data not available in the input).
The report is designed to inform billing, clinical documentation, and policy stakeholders about the clinical role of CPT code 35665, typical care settings, and payer coverage considerations. It also highlights areas where additional coding detail or payer-specific policy information would be needed to support claims submission and authorization workflows.
Billing Code Overview
CPT code 35665 describes surgical bypass of an occluded or stenotic iliac artery using a synthetic graft to establish inflow to the femoral artery. The procedure reroutes blood flow around an iliac arterial blockage by creating a conduit from the iliac circulation to the femoral circulation using a prosthetic graft.
Service type: Arterial bypass surgery
Typical site of service: Operating room / Inpatient surgical setting, often performed in a hospital surgical suite with postoperative inpatient care for vascular surgery patients.
Clinical & Coding Specifications
Clinical Context
A 68-year-old male with a history of peripheral arterial disease and smoking presents with progressive left lower extremity claudication and diminished distal pulses. Noninvasive vascular studies (ABI, arterial duplex) demonstrate a significant occlusive lesion of the left common iliac artery with reduced ankle-brachial index and evidence of tissue ischemia during exertion. The vascular surgeon schedules an open iliac-to-femoral bypass using a synthetic graft to reestablish inflow to the femoral artery and relieve ischemia.
Preoperative workflow includes vascular imaging (CT angiography or conventional angiography) to map the lesion and inflow/outflow vessels, medical optimization (antiplatelet therapy, statin management), informed consent discussing risks and benefits, and anesthesia evaluation. Intraoperatively, the surgeon exposes the iliac artery and common femoral artery, constructs proximal and distal anastomoses with a synthetic graft (typically Dacron or PTFE), verifies graft patency, and achieves hemostasis. Postoperative care involves vascular monitoring, limb perfusion checks, anticoagulation/antiplatelet management per protocol, wound care, and surveillance imaging as indicated. Typical sites of service are an inpatient hospital operating room or an ambulatory surgical center when clinically appropriate. The service type is surgical vascular bypass (open arterial revascularization).
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component |